Psychedelic Compound-Based Drug Stock, Mind Medicine, Up 56% Last Week
March 11, 2024 at 14:29 PM EDT
The FDA has granted breakthrough designation to Mind Medicine's program for the treatment of generalized anxiety disorder.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
